Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Neoplasm Metastasis 2Sarcoma 1Recurrence 1Liver Diseases 1Digestive System Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 18Oxaliplatin 17Capecitabine 16Leucovorin 13Cisplatin 12Gemcitabine 11Drug Therapy 11Irinotecan 10Radiosurgery 9Cetuximab 9Bevacizumab 9pembrolizumab 8Docetaxel 8Everolimus 7spartalizumab 6Sunitinib 6Radiotherapy 6Paclitaxel 6Neoadjuvant Therapy 6Cyclophosphamide 6Trastuzumab 5S 1 (combination) 5Nivolumab 5Immunotherapy 5Immune Checkpoint Inhibitors 5Chemotherapy, Adjuvant 5Carboplatin 5palbociclib 4manganese chloride 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neoplasm Metastasis × Microspheres × Clear all
NCT02208804 2016-11-09

SIM

UMC Utrecht

Phase 2/3 Unknown
25 enrolled
Gastrointestinal

Digestive System Neoplasms, Liver Diseases, Neoplasm Metastasis, Colorectal Neoplasms

NCT01898962 2013-07-15

Definitive Therapy for Oligometastatic Solid Malignancies

Rocky Mountain Cancer Centers

Phase 2 Unknown
110 enrolled
Sarcoma

Neoplasm Metastasis, Recurrence, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡